Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiac Safety of Atypical Antipsychotics in Schizophrenia
NCT04446234Phase 4Unknown
- Sponsor
- Shanghai Mental Health Center
- Start
- May 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of risperidone, aripiprazole, ziprasidone, amisulpride, quetiapine in schizophrenia, sponsored by Shanghai Mental Health Center. Status: unknown.
02
Drugs
risperidonearipiprazoleziprasidoneamisulpridequetiapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT04446234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04446234.